Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP482910.RAXdJYtlbg_6HI95-kwUuhT_vwxpKYB7tvijzhQjWXkPg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP482910.RAXdJYtlbg_6HI95-kwUuhT_vwxpKYB7tvijzhQjWXkPg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP482910.RAXdJYtlbg_6HI95-kwUuhT_vwxpKYB7tvijzhQjWXkPg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP482910.RAXdJYtlbg_6HI95-kwUuhT_vwxpKYB7tvijzhQjWXkPg130_provenance.
- NP482910.RAXdJYtlbg_6HI95-kwUuhT_vwxpKYB7tvijzhQjWXkPg130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP482910.RAXdJYtlbg_6HI95-kwUuhT_vwxpKYB7tvijzhQjWXkPg130_provenance.
- NP482910.RAXdJYtlbg_6HI95-kwUuhT_vwxpKYB7tvijzhQjWXkPg130_assertion evidence source_evidence_literature NP482910.RAXdJYtlbg_6HI95-kwUuhT_vwxpKYB7tvijzhQjWXkPg130_provenance.
- NP482910.RAXdJYtlbg_6HI95-kwUuhT_vwxpKYB7tvijzhQjWXkPg130_assertion SIO_000772 11877595 NP482910.RAXdJYtlbg_6HI95-kwUuhT_vwxpKYB7tvijzhQjWXkPg130_provenance.
- NP482910.RAXdJYtlbg_6HI95-kwUuhT_vwxpKYB7tvijzhQjWXkPg130_assertion wasDerivedFrom befree-20140225 NP482910.RAXdJYtlbg_6HI95-kwUuhT_vwxpKYB7tvijzhQjWXkPg130_provenance.
- NP482910.RAXdJYtlbg_6HI95-kwUuhT_vwxpKYB7tvijzhQjWXkPg130_assertion wasGeneratedBy ECO_0000203 NP482910.RAXdJYtlbg_6HI95-kwUuhT_vwxpKYB7tvijzhQjWXkPg130_provenance.
- befree-20140225 importedOn "2014-02-25" NP482910.RAXdJYtlbg_6HI95-kwUuhT_vwxpKYB7tvijzhQjWXkPg130_provenance.